{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "79ee30a3",
   "metadata": {},
   "source": [
    "# Azure AI Language Challenge\n",
    "\n",
    "Demonstrate the following features of Azure AI Language using the documents provided:\n",
    "1. Sentiment Analysis and Opinion Mining on Customer Feedback for Document 1 only\n",
    "2. Named Entity Recognition\n",
    "3. Key Phrase Extraction\n",
    "4. Text Summarization (Extractive Summarization for 5 sentences and Abstractive Summarization)\n",
    "5. PII Detection\n",
    "6. Text Analytics Health for Document 2 only"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "bdd7aec5",
   "metadata": {},
   "source": [
    "## Document 1\n",
    "\n",
    "Title: Annual Report on Company Performance\n",
    "\n",
    "Introduction: The year 2024 has been a remarkable period for XYZ Corporation. Despite the global economic challenges, we have achieved significant milestones in our journey towards innovation and sustainability.\n",
    "\n",
    "Financial Overview: Our revenue for the fiscal year 2024 was $5.2 billion, marking a 10% increase from the previous year. The net profit stood at $1.1 billion, reflecting our efficient cost management and strategic investments.\n",
    "\n",
    "Key Achievements:\n",
    "\n",
    "Product Launches: We successfully launched three new products - the XYZ Smartwatch, XYZ Home Assistant, and XYZ Electric Scooter. These products have received positive feedback from customers and industry experts alike.\n",
    "\n",
    "Sustainability Initiatives: Our commitment to sustainability was reinforced by reducing our carbon footprint by 20% and increasing the use of renewable energy sources in our operations.\n",
    "\n",
    "Market Expansion: We expanded our market presence to five new countries, including Brazil, India, and South Africa, enhancing our global footprint.\n",
    "\n",
    "Customer Feedback: Customer satisfaction remains a top priority for us. We conducted surveys and received over 10,000 responses, with 85% of customers expressing satisfaction with our products and services. However, some customers highlighted areas for improvement, particularly in customer support and delivery times.\n",
    "\n",
    "Challenges: The primary challenges we faced included supply chain disruptions and fluctuating market demands. We are actively working on strategies to mitigate these issues and ensure seamless operations.\n",
    "\n",
    "Future Outlook: Looking ahead, we aim to continue our growth trajectory by focusing on innovation, customer-centric solutions, and sustainable practices. Our goal is to achieve a 15% revenue growth in the next fiscal year.\n",
    "\n",
    "Conclusion: We are grateful to our employees, partners, and customers for their unwavering support. Together, we will strive to reach new heights and make a positive impact on the world.\n",
    "\n",
    "Contact Information: For more details, please contact John Doe, Chief Financial Officer, at john.doe@xyzcorp.com or call (123) 456-7890."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "78a5800f",
   "metadata": {},
   "source": [
    "## Document 2\n",
    "\n",
    "Patient Information:\n",
    "\n",
    "Name: Jane Doe\n",
    "Date of Birth: March 15, 1985\n",
    "Gender: Female\n",
    "Medical Record Number: 123456789\n",
    "\n",
    "Visit Information:\n",
    "\n",
    "Date of Visit: April 10, 2025\n",
    "Physician: Dr. John Smith\n",
    "Department: Cardiology\n",
    "Chief Complaint: Jane Doe presented with complaints of chest pain and shortness of breath that started two days ago. She describes the pain as sharp and localized to the left side of her chest.\n",
    "\n",
    "History of Present Illness: The patient reports that the chest pain began suddenly while she was at rest. She denies any recent physical exertion or trauma. The pain is exacerbated by deep breathing and relieved by sitting up. She also reports episodes of dizziness and palpitations.\n",
    "\n",
    "Past Medical History:\n",
    "\n",
    "Hypertension\n",
    "Hyperlipidemia\n",
    "Asthma\n",
    "\n",
    "Medications:\n",
    "\n",
    "Lisinopril 10 mg daily\n",
    "Atorvastatin 20 mg daily\n",
    "Albuterol inhaler as needed\n",
    "Allergies:\n",
    "\n",
    "Penicillin\n",
    "\n",
    "Family History:\n",
    "\n",
    "Father: Hypertension, myocardial infarction at age 60\n",
    "Mother: Type 2 diabetes\n",
    "\n",
    "Social History:\n",
    "\n",
    "Non-smoker\n",
    "Occasional alcohol consumption\n",
    "Works as a software engineer\n",
    "\n",
    "Review of Systems:\n",
    "\n",
    "Cardiovascular: Positive for chest pain and palpitations\n",
    "Respiratory: Positive for shortness of breath, negative for cough\n",
    "Gastrointestinal: Negative for nausea, vomiting, or abdominal pain\n",
    "Neurological: Positive for dizziness, negative for headaches or seizures\n",
    "\n",
    "Physical Examination:\n",
    "\n",
    "Vital Signs: Blood pressure 150/90 mmHg, heart rate 95 bpm, respiratory rate 18 breaths per minute, temperature 98.6Â°F\n",
    "General: Alert and oriented, no acute distress\n",
    "Cardiovascular: Regular rhythm, no murmurs, rubs, or gallops\n",
    "Respiratory: Clear to auscultation bilaterally, no wheezing or crackles\n",
    "Abdomen: Soft, non-tender, no organomegaly\n",
    "Neurological: Cranial nerves intact, no focal deficits\n",
    "Diagnostic Tests:\n",
    "\n",
    "Electrocardiogram (ECG): Normal sinus rhythm, no ST-segment changes\n",
    "Chest X-ray: No acute cardiopulmonary abnormalities\n",
    "Blood Tests: Elevated troponin levels, normal complete blood count (CBC), normal electrolytes\n",
    "Assessment: The patient is diagnosed with acute coronary syndrome (ACS) based on her symptoms and elevated troponin levels.\n",
    "\n",
    "Plan:\n",
    "\n",
    "Admit to the hospital for further monitoring and management.\n",
    "Initiate aspirin 81 mg daily and clopidogrel 75 mg daily.\n",
    "Continue current medications for hypertension and hyperlipidemia.\n",
    "Consult cardiology for possible coronary angiography.\n",
    "Educate the patient on lifestyle modifications and the importance of medication adherence.\n",
    "Follow-Up: The patient will be re-evaluated in 24 hours and monitored for any changes in her condition.\n",
    "\n",
    "Signature: Dr. John Smith, MD"
   ]
  }
 ],
 "metadata": {
  "language_info": {
   "name": "python"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
